Cargando…
Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach
The blind subterranean mole rat Spalax shows a remarkable tolerance to hypoxia, cancer-resistance and longevity. Unravelling the genomic basis of these adaptations will be important for biomedical applications. RNA-Seq gene expression data were obtained from normoxic and hypoxic Spalax and rat liver...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662568/ https://www.ncbi.nlm.nih.gov/pubmed/29084988 http://dx.doi.org/10.1038/s41598-017-13905-z |
_version_ | 1783274654806310912 |
---|---|
author | Schmidt, Hanno Malik, Assaf Bicker, Anne Poetzsch, Gesa Avivi, Aaron Shams, Imad Hankeln, Thomas |
author_facet | Schmidt, Hanno Malik, Assaf Bicker, Anne Poetzsch, Gesa Avivi, Aaron Shams, Imad Hankeln, Thomas |
author_sort | Schmidt, Hanno |
collection | PubMed |
description | The blind subterranean mole rat Spalax shows a remarkable tolerance to hypoxia, cancer-resistance and longevity. Unravelling the genomic basis of these adaptations will be important for biomedical applications. RNA-Seq gene expression data were obtained from normoxic and hypoxic Spalax and rat liver tissue. Hypoxic Spalax broadly downregulates genes from major liver function pathways. This energy-saving response is likely a crucial adaptation to low oxygen levels. In contrast, the hypoxia-sensitive rat shows massive upregulation of energy metabolism genes. Candidate genes with plausible connections to the mole rat’s phenotype, such as important key genes related to hypoxia-tolerance, DNA damage repair, tumourigenesis and ageing, are substantially higher expressed in Spalax than in rat. Comparative liver transcriptomics highlights the importance of molecular adaptations at the gene regulatory level in Spalax and pinpoints a variety of starting points for subsequent functional studies. |
format | Online Article Text |
id | pubmed-5662568 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-56625682017-11-08 Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach Schmidt, Hanno Malik, Assaf Bicker, Anne Poetzsch, Gesa Avivi, Aaron Shams, Imad Hankeln, Thomas Sci Rep Article The blind subterranean mole rat Spalax shows a remarkable tolerance to hypoxia, cancer-resistance and longevity. Unravelling the genomic basis of these adaptations will be important for biomedical applications. RNA-Seq gene expression data were obtained from normoxic and hypoxic Spalax and rat liver tissue. Hypoxic Spalax broadly downregulates genes from major liver function pathways. This energy-saving response is likely a crucial adaptation to low oxygen levels. In contrast, the hypoxia-sensitive rat shows massive upregulation of energy metabolism genes. Candidate genes with plausible connections to the mole rat’s phenotype, such as important key genes related to hypoxia-tolerance, DNA damage repair, tumourigenesis and ageing, are substantially higher expressed in Spalax than in rat. Comparative liver transcriptomics highlights the importance of molecular adaptations at the gene regulatory level in Spalax and pinpoints a variety of starting points for subsequent functional studies. Nature Publishing Group UK 2017-10-30 /pmc/articles/PMC5662568/ /pubmed/29084988 http://dx.doi.org/10.1038/s41598-017-13905-z Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Schmidt, Hanno Malik, Assaf Bicker, Anne Poetzsch, Gesa Avivi, Aaron Shams, Imad Hankeln, Thomas Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach |
title | Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach |
title_full | Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach |
title_fullStr | Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach |
title_full_unstemmed | Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach |
title_short | Hypoxia tolerance, longevity and cancer-resistance in the mole rat Spalax – a liver transcriptomics approach |
title_sort | hypoxia tolerance, longevity and cancer-resistance in the mole rat spalax – a liver transcriptomics approach |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662568/ https://www.ncbi.nlm.nih.gov/pubmed/29084988 http://dx.doi.org/10.1038/s41598-017-13905-z |
work_keys_str_mv | AT schmidthanno hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach AT malikassaf hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach AT bickeranne hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach AT poetzschgesa hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach AT aviviaaron hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach AT shamsimad hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach AT hankelnthomas hypoxiatolerancelongevityandcancerresistanceinthemoleratspalaxalivertranscriptomicsapproach |